Revvity, Inc. (RVTY) stock analysis

In our weekly check, Revvity, Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 7.

About Revvity, Inc.

Revvity, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NYSE as RVTY.

What our checks show for RVTY

Red flags

Warning signs

Strengths

Next earnings report: 2027-02-01

Similar companies

MEDP · CRL · ICLR · GH · DGX · QGEN

Questions

What grade does Revvity, Inc. (RVTY) have?

In our weekly check, Revvity, Inc. is graded C (A to F). Of 25 checks on debt, profit, cash flow and trend: 13 pass, warnings: 5, red flags: 7. The grade is a risk check, not a buy or sell recommendation.

What are the main risks of RVTY stock?

This week's biggest flags for Revvity, Inc.: Margins falling, Gross margin falling, Weak revenue growth. In total 12 of 25 checks show a warning or a red flag.

What does Revvity, Inc. do?

Revvity, Inc. is a Healthcare company (Medical - Diagnostics & Research) based in the United States, listed on NYSE as RVTY.

When does Revvity, Inc. report earnings next?

The next earnings report is expected on 2027-02-01. We re-run the checks every week, so the grade can change after it.

The grade is a risk check, not a price forecast, and not investment advice. In our 10-year test (S&P 500, 2016-2026), stocks we graded A or B fell more than 30% 2-3 times less often than D or F, without a lower average return.

Updated 2026-11-14

Open the full analysis